一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Cancer Science >>article
Cancer Science

Cancer Science

IF: 4.5
Download PDF

LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo.

Published:2 December 2021 DOI: 10.1111/cas.15229 PMID: 34855271
Yingqiang Liu, Mengzhen Lai, Shan Li, Yanan Wang, Fang Feng, Tao Zhang, Linjiang Tong, Mengge Zhang, Hao Chen, Yi Chen, Peiran Song, Yan Li, Gang Bai, Yi Ning, Haotian Tang, Yan Fang, Yi Chen, Xiaoyun Lu, Meiyu Geng, Ke Ding, Ker Yu, Hua Xie, Jian Ding

Abstract

With the wide clinical use of the third-generation epidermal growth factor receptor (EGFR) inhibitor osimertinib for the treatment of EGFR-mutated non–small cell lung cancer (NSCLC), acquired resistance caused by EGFR C797S tertiary mutation has become a concern. Therefore, fourth-generation EGFR inhibitors that could overcome this mutation have gained increasing attention in recent years. Here, we identified LS-106 as a novel EGFR inhibitor against C797S mutation and evaluated its antitumor activity both in vitro and in vivo. In cell-free assay, LS-106 potently inhibited the kinase activities of EGFR19del/T790M/C797S and EGFRL858R/T790M/C797S with IC50 values of 2.4?nmol/L and 3.1?nmol/L, respectively, which was more potent than osimertinib. Meanwhile, LS-106 exhibited comparable kinase inhibitory effect to osimertinib on EGFRL858R/T790M and wild-type EGFR. Results from cellular experiments demonstrated that LS-106 potently blocked the phosphorylation of EGFR C797S triple mutations in the constructed BaF3 cells that highly expressed EGFR19del/T790M/C797S or EGFRL858R/T790M/C797S, and thus inhibited the proliferation of these cells. We also constructed tumor cells harboring EGFR19del/T790M/C797S (named PC-9-OR cells) using the CRISPR/Cas9 system and found that LS-106 markedly suppressed the activation of EGFR19del/T790M/C797S and the proliferation of PC-9-OR cells. Moreover, cells harboring EGFR19del/T790M/C797S underwent remarkable apoptosis upon LS-106 treatment. In vivo experiments further demonstrated that oral administration of LS-106 caused significant tumor regression in a PC-9-OR xenograft model, with a tumor growth inhibition rate (TGI) of 83.5% and 136.6% at doses of 30 and 60?mg/kg, respectively. Taken together, we identified LS-106 as a novel fourth-generation EGFR inhibitor against C797S mutation and confirmed its preclinical antitumor effects in C797S–triple-mutant tumor models.

Substances (6)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
AZD-9291 1421373-65-0 C28H33N7O2 429 suppliers $4.00-$1800.00
AZD-9291 1421373-65-0 C28H33N7O2 429 suppliers $4.00-$1800.00
AZD9291 1421373-65-0 - Inquiry
AZD9291 1421373-65-0 - Inquiry

Similar articles

IF:5.7

4-Methylumbelliferone Inhibits Angiogenesis in Vitro and in Vivo

Journal of Agricultural and Food Chemistry Javier A. García-Vilas, Ana R. Quesada,etc Published: 12 April 2013
IF:4.6

In Vitro and In Vivo Neuroprotective Effects of Sarcosine.

ACS Applied Bio Materials Arzugül Tanas, ?zlem ?zdemir Tozlu,etc Published: 15 October 2022
天津市| 汝南县| 兴和县| 石楼县| 九龙坡区| 分宜县| 青田县| 汨罗市| 红桥区| 海林市| 池州市| 漳州市| 云霄县| 海伦市| 虹口区| 军事| 富宁县| 噶尔县| 安顺市| 延津县| 东宁县| 那曲县| 周口市| 石林| 内江市| 吴江市| 平武县| 滨海县| 炉霍县| 朝阳县| 崇左市| 台东县| 宁阳县| 布尔津县| 鄂伦春自治旗| 房山区| 禄丰县| 司法| 平潭县| 周口市| 毕节市|